Yükleniyor... / Loading...
Encodes activation-induced cytidine deaminase. Mutations cause hyper-IgM syndrome type 2.
Clinical trials have approximately 10% success rate. This roadmap shows the current status, not guaranteed outcomes.
AICDA No associated disease records found for this gene.